5 The study also reported “marked improvements” in rhonchi, crepitations, dyspnea, cyanosis, and associated heart failure after one to two months of therapy. 2 An open-label study of 1,392 patients found that N-acetylcysteine reduced the viscosity of expectorated phlegm, reduced cough severity, and improved ease of expectoration in 80, 74, and 71 percent of patients, respectively, after two months of treatment. N-acetylcysteine has been shown to have a positive effect on the clinical course of COPD.
0 kommentar(er)
